MediSix Therapeutics Email Format

Biotechnology ResearchCentral Region, Singapore11-50 Employees

MediSix Therapeutics is a biotechnology research company focused on developing T-cell therapies to treat cancer and autoimmune diseases. Based in Singapore, the firm aims to enhance and expand T cell function through a range of proprietary technologies, addressing clinical needs in oncology and immune-related conditions. With a footprint in the biotechnology sector, MediSix positions itself as a development-stage company pursuing novel cell therapies for T-cell leukemia and lymphoma.

 The organization operates within a competitive frontier of immune-based therapeutics, targeting researchers and clinicians seeking new treatment modalities for difficult-to-treat cancers and autoimmune disorders. Located in the Central Region of Singapore, MediSix advances its mission from its base at 11 Biopolis Way, Helios, contributing to the broader biotech ecosystem in the region.

Sign up for free to view info

Company overview Employee directory